This inventor holds 6 USPTO granted patents. Top assignees: Tri-Institutional Therapeutics Discovery Institute, Cornell University, Sloan-Kettering Institute for Cancer Research. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021-2025
Title: Kazuyoshi Aso: Innovator in Macrocyclic Compounds
Introduction
Kazuyoshi Aso is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of macrocyclic compounds. With a total of 6 patents, Aso's work focuses on innovative solutions for various health-related issues.
Latest Patents
Aso's latest patents include the development of macrocyclic compounds as proteasome inhibitors. These compounds are represented by specific formulas where the substituents R, R', R'', X, Y, and Z are defined in detail. The applications of these compounds are extensive, as they are utilized in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases, inflammatory disorders, and muscular dystrophy. Additionally, they provide immunosuppression for transplanted organs or tissues.
Career Highlights
Throughout his career, Kazuyoshi Aso has worked with esteemed institutions such as Cornell University and the Tri-Institutional Therapeutics Discovery Institute. His research has significantly advanced the understanding and treatment of various diseases through innovative chemical compounds.
Collaborations
Aso has collaborated with notable colleagues, including Michael Andrew Foley and Wenhu Zhan. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Kazuyoshi Aso's contributions to the field of medicinal chemistry through his innovative macrocyclic compounds have the potential to impact the treatment of numerous health conditions. His work exemplifies the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile